Liquidia Financial Statements From 2010 to 2025
| LQDA Stock | USD 14.79 0.36 2.49% |
Check Liquidia Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Liquidia Technologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . Liquidia financial statements analysis is a perfect complement when working with Liquidia Technologies Valuation or Volatility modules.
Liquidia |
Liquidia Technologies Company Return On Asset Analysis
Liquidia Technologies' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Liquidia Technologies Return On Asset | -0.38 |
Most of Liquidia Technologies' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Liquidia Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Liquidia Technologies has a Return On Asset of -0.3828. This is 95.63% lower than that of the Pharmaceuticals sector and 98.38% lower than that of the Health Care industry. The return on asset for all United States stocks is 173.43% higher than that of the company.
Liquidia Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Liquidia Technologies's current stock value. Our valuation model uses many indicators to compare Liquidia Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Liquidia Technologies competition to find correlations between indicators driving Liquidia Technologies's intrinsic value. More Info.Liquidia Technologies is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Liquidia Technologies' earnings, one of the primary drivers of an investment's value.About Liquidia Technologies Financial Statements
Liquidia Technologies stakeholders use historical fundamental indicators, such as Liquidia Technologies' revenue or net income, to determine how well the company is positioned to perform in the future. Although Liquidia Technologies investors may analyze each financial statement separately, they are all interrelated. For example, changes in Liquidia Technologies' assets and liabilities are reflected in the revenues and expenses on Liquidia Technologies' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Liquidia Technologies. Please read more on our technical analysis and fundamental analysis pages.
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. Liquidia Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Liquidia Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Liquidia Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Liquidia Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Liquidia Technologies Stock:Check out the analysis of Liquidia Technologies Correlation against competitors. For information on how to trade Liquidia Stock refer to our How to Trade Liquidia Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Liquidia Technologies. If investors know Liquidia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Liquidia Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Liquidia Technologies is measured differently than its book value, which is the value of Liquidia that is recorded on the company's balance sheet. Investors also form their own opinion of Liquidia Technologies' value that differs from its market value or its book value, called intrinsic value, which is Liquidia Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Liquidia Technologies' market value can be influenced by many factors that don't directly affect Liquidia Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Liquidia Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Liquidia Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Liquidia Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.